Link to Zipped WordPerfect Minutes 6K bytes
HOUSE HEALTH AND HUMAN SERVICES STANDING COMMITTEE
ROOM 25, HOUSE OFFICE BUILDING, STATE CAPITOL COMPLEX
February 19, 2010
Rep. Ronda R. Menlove, Vice Chair
Rep. Trisha S. Beck
Rep. Bradley M. Daw
Rep. Phil Riesen
Rep. Stephen E. Sandstrom
Rep. Evan J. Vickers
STAFF PRESENT: Mark D. Andrews, Policy Analyst
Sylvia Newton, House Secretary
Note: A list of visitors and copy of handouts are filed with committee minutes.
Rep. Ray called the meeting to order at 8:38 a.m. and welcomed a group of students from Uintah High School.
MOTION: Rep. Vickers moved to approve the minutes of the February 16, 2010 meeting. The motion passed unanimously with Rep. Sandstrom absent for the vote.
H.B. 104 Unlawful Provision of Identifiable Prescription Information (Rep. J. Biskupski)
This bill was not considered.
H.B. 311 Autism Treatment Fund (Rep. R. Lockhart)
MOTION: Rep. Menlove moved to adopt 1st Substitute H.B. 311. The motion passed unanimously with Rep. Sandstrom absent for the vote.
Rep. Lockhart explained the substitute bill to the committee.
MOTION: Rep. Daw moved to pass the bill with a favorable recommendation. The motion passed unanimously with Rep. Sandstrom absent for the vote.
MOTION: Rep. Menlove moved to place 1st Substitute H.B. 311 on the Consent Calendar. The motion passed unanimously with Rep. Sandstrom absent for the vote.
S.B. 41S1 Drug Utilization Review Board Amendments (Sen. P. Knudson)
Sen. Knudson explained the bill to the committee, assisted by Tim Morley, Utah Department of Health and member of the Drug Utilization Review Board.
Rep. Ray relinquished the chair to Rep. Menlove.
Spoke in opposition to the bill: Michael Mason, psychiatrist, Valley Mental Health
Richard Montano, Epilepsy Association of Utah
During the discussion Rep. Ray resumed the chair.
MOTION: Rep. Sandstrom moved to amend the bill as follows:
1. Page 3, Lines 70 through 78
House Committee Amendments
2-18-2010 :
70 (2) H. [
only
after
70a complying with Subsections (1)(b) through (j) .H , consider the cost:
71 H. [
72 H. [
72a process,
73 including:
74 H. [
75 H. [
75a of a
76 drug's inclusion on the prior approval process.
77 H. [
78 Subsections (1)(b) through (j) apply.
The motion to amend the bill passed unanimously with Rep. Menlove absent for the vote.
MOTION: Rep. Daw moved to pass 1st Substitute S.B. 41 with a favorable recommendation. The motion passed with Rep. Ray voting in opposition to the motion and Rep. Menlove absent for the vote.
MOTION: Rep. Riesen moved to adjourn the meeting. The motion passed unanimously with Rep. Menlove absent for the vote.
Rep. Ray adjourned the meeting at 9:38 a.m.
__________________
Rep. Paul Ray
Committee Chair